KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $2.5 million.

  • Biolife Solutions' Cost of Revenue rose 83.77% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 3754.08%. This contributed to the annual value of $9.6 million for FY2024, which is 2438.43% down from last year.
  • As of Q3 2025, Biolife Solutions' Cost of Revenue stood at $2.5 million, which was up 83.77% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Cost of Revenue peaked at $6.5 million during Q1 2023, and registered a low of -$3.9 million during Q4 2022.
  • Over the past 5 years, Biolife Solutions' median Cost of Revenue value was $2.7 million (recorded in 2025), while the average stood at $3.1 million.
  • As far as peak fluctuations go, Biolife Solutions' Cost of Revenue plummeted by 18223.11% in 2022, and later surged by 1030000.0% in 2024.
  • Biolife Solutions' Cost of Revenue (Quarter) stood at $4.8 million in 2021, then tumbled by 182.23% to -$3.9 million in 2022, then surged by 99.44% to -$22000.0 in 2023, then surged by 10300.0% to $2.2 million in 2024, then rose by 12.66% to $2.5 million in 2025.
  • Its Cost of Revenue was $2.5 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.6 million in Q1 2025.